Niraparib
Spécifications
1038915-60-4Numéro CAS
685-112-3Numéro CE
2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamideNom IUPAC
C19H20N4OFormule chimique
320.4 g/molMasse molaire
Niraparib; 1038915-60-4; MK4827; 2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide; 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide; HMC2H89N35; ZL-2306; JNJ-64091742; CHEBI:176844; DTXSID50146129; niraparibum; 2-(4-((3S)-piperidin-3-yl)phenyl)indazole-7-carboxamide; 2-(4-((3S)-PIPERIDIN-3-YL)PHENYL)-2H-INDAZOLE-7-CARBOXAMIDE; RefChem:57941; DTXCID8068620; L01XX54; 685-112-3; MK-4827; (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide; MFCD17779309; 2-[4-(3S)-3-Piperidinylphenyl]-2H-indazole-7-carboxamide; Niraparib [USAN]; C19H20N4O; CHEMBL1094636; Niraparib (USAN); 2-[4-[(3S)-3-Piperidyl]phenyl]indazole-7-carboxamide; 2H-Indazole-7-carboxamide, 2-[4-(3S)-3-piperidinylphenyl]-; Niraparib (MK-4827); Niraparib [USAN:INN]; UNII-HMC2H89N35; MK 4827 (Base); 2H-INDAZOLE-7-CARBOXAMIDE, 2-(4-(3S)-3-PIPERIDINYLPHENYL)-; 3JD; Niraparib (Standard); NIRAPARIB [INN]; NIRAPARIB [MI]; MK-4827 (Niraparib); NIRAPARIB [WHO-DD]; GTPL8275; orb1227085; orb1304399; orb3141361; SCHEMBL1421875; (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide;MK-4827; Niraparib(MK4827) free base?; EX-A290; GLXC-90531; MK-4827 (PARP-1); BDBM50316226; EBC-17059; HY-10619R; MSK168159; NSC754355; NSC800020; AKOS016004869; CCG-267709; compound 56 [PMID 19873981]; CS-0780; DB11793; FP35532; NSC-754355; NSC-800020; NCGC00346435-01; NCGC00346435-04; NCGC00346435-12; NCGC00346435-13; AC-28447; AS-35248; BP-44033; HY-10619; SY105306; Akeega (niraparib and abiraterone acetate); 5129B; 5142B; NS00072574; D10140; EN300-7364833; F227536; BRD-K54955827-001-01-4; BRD-K54955827-001-02-2; Q25326660; (S)-2(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide; 2H-Indazole-7-carboxamide, 2-[4-(3S)-3-piperidinylphenyl]Synonymes
